Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants-Reference-Cited by-同舟云学术

Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants

Published:2021-07-05 Issue:5 Volume:36 Page:934-947
ISSN:1674-0769
Container-title:Virologica Sinica
language:en
Short-container-title:Virol. Sin.

Author:

Qu Yuanyuan,Zhang Xueyan,Wang Meiyu,Sun Lina,Jiang Yongzhong,Li Cheng,Wu Wei,Chen Zhen,Yin Qiangling,Jiang Xiaolin,Liu Yang,Li Chuan,Li Jiandong,Ying Tianlei,Li Dexin,Zhan Faxian,Wang Youchun,Guan Wuxiang^ORCID,Wang Shiwen^ORCID,Liang Mifang^ORCID

Publisher

Elsevier BV

Subject

Virology,Molecular Medicine,Immunology

Link

https://link.springer.com/content/pdf/10.1007/s12250-021-00409-4.pdf

Reference47 articles.

1. Barbas CF, Burton DR (1996) Selection and evolution of high-affinity human anti-viral antibodies. Trends Biotechnol 14:230–234

2. Barbas CF, Kang AS, Lerner RA, Benkovic SJ (1991) Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A 88:7978–7982

3. Barnes CO, Jette CA, Abernathy ME, Dam KA, Esswein SR, Gristick HB, Malyutin AG, Sharaf NG, Huey-Tubman KE, Lee YE, Robbiani DF, Nussenzweig MC, West AP Jr, Bjorkman PJ (2020) SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 588:682–687

4. Benton DJ, Wrobel AG, Xu P, Roustan C, Martin SR, Rosenthal PB, Skehel JJ, Gamblin SJ (2020) Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion. Nature 588:327–330

5. Bertoglio F, Meier D, Langreder N, Steinke S, Rand U, Simonelli L, Heine PA, Ballmann R, Schneider KT, Roth KDR, Ruschig M, Riese P, Eschke K, Kim Y, Schäckermann D, Pedotti M, Kuhn P, Zock-Emmenthal S, Wöhrle J, Kilb N, Herz T, Becker M, Grasshoff M, Wenzel EV, Russo G, Kröger A, Brunotte L, Ludwig S, Fühner V, Krämer SD, Dübel S, Varani L, Roth G, Čičin-Šain L, Schubert M, Hust M (2021) SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface. Nature Commun 12:1577

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The generation of hemagglutinin monoclonal antibodies against H9N2 influenza virus;Animal Diseases;2023-11-27

2. Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China;Emerging Microbes & Infections;2023-11-16

3. Current state-of-the-art and potential future therapeutic drugs against COVID-19;Frontiers in Cell and Developmental Biology;2023-08-25

4. Research and development of Chinese anti-COVID-19 drugs;Acta Pharmaceutica Sinica B;2022-12

5. Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages;Cell Discovery;2022-09-08